Springer期刊
期刊
会议
图书
作者:... William John , Allen Melemed , Astra M. Liepa
来源:[J].Health and Quality of Life Outcomes(IF 2.272), 2016, Vol.14 (1)Springer
摘要:Abstract(#br) Background(#br)Patient-reported outcomes have been associated with survival in numerous studies across cancer types, including breast cancer. However, the Brief Pain Inventory-Short Form (BPI-SF) and the Rotterdam Symptom Checklist (RSCL) have rarely been inves...
作者:Astra M. Liepa , Zhanglin Lin Cui ...
来源:[J].Gastric Cancer(IF 3.989), 2018, Vol.21 (5), pp.831-844Springer
摘要:Abstract(#br) Background(#br)Limited real-world research has investigated ramucirumab for the treatment of patients with gastric or gastroesophageal junction (GEJ) cancer. This study was designed to describe ramucirumab monotherapy or combination therapy use in a community o...
作者:... William Schelman , Astra M. Liepa , Charles Fuchs
来源:[J].Gastric Cancer(IF 3.989), 2018, Vol.21 (5), pp.738-744Springer
摘要:Abstract(#br) Background(#br)Patients with metastatic gastric cancer have a poor prognosis (5-year survival of less than 10%). This study was designed to describe the treatment patterns of patients with gastric cancer and to understand the factors associated with treatment c...
作者:... Julie Beyrer , Astra M. Liepa , Steven Nicol
来源:[J].Gastric Cancer(IF 3.989), 2016, Vol.19 (2), pp.607-615Springer
摘要:Abstract(#br) Background(#br)The aim of this study was to conduct a retrospective database analysis to describe the chemotherapy treatment patterns and outcomes of patients with gastric cancer.(#br) Methods(#br)Individuals diagnosed with gastric cancer were identified from t...
作者:Astra M. Liepa , Allen S. Melemed ...
来源:[J].Quality of Life Research(IF 2.412), 2012, Vol.21 (5), pp.765-775Springer
摘要:Abstract(#br) Purpose(#br)This manuscript presents health-related quality of life (HRQL) results from a phase III trial of gemcitabine-paclitaxel (GT) versus paclitaxel (T) in metastatic breast cancer patients.(#br) Methods(#br)Patients completed the Rotterdam Symptom Checklist (...
作者:Astra M. Liepa , Guido Moeser ...
来源:[J].Health Economics Review, 2018, Vol.8 (1), pp.1-10Springer
摘要:Abstract(#br) Objective(#br)To estimate both the number of patients with hepatocellular carcinoma (HCC) eligible annually for second-line therapy following sorafenib in Germany and the healthcare costs accrued by patients meeting eligibility criteria.(#br) Methods(#br)Patien...
作者:Astra M. Liepa , James T. Symanowski
来源:[J].Supportive Care in Cancer(IF 2.649), 2006, Vol.14 (1), pp.11-21Springer
摘要:Abstract(#br)Health-related quality of life (QOL) assessment is a key component in patient assessment and the development of therapies for malignant pleural mesothelioma. However, no mesothelioma-specific instrument was available. The Lung Cancer Symptom Scale (LCSS), a site...
作者:... Anna Marie Hayden , Astra M. Liepa , William J. John
来源:[J].American Journal of Cancer, 2005, Vol.4 (3), pp.185-191Springer
摘要:Abstract(#br) Background: Gemcitabine is the standard chemotherapy for the treatment of advanced pancreatic cancer. The novel multitargeted antifolate pemetrexed (Alimta®) has also demonstrated activity in this disease. These two drugs are synergistic in vitro , and a phase ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×